Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Bio-Feedback to Improving Stability in Elderly Population
This study is ongoing, but not recruiting participants.
Sponsored by: Tel-Aviv Sourasky Medical Center
Information provided by: Tel-Aviv Sourasky Medical Center
ClinicalTrials.gov Identifier: NCT00716261
  Purpose

Our hypothesis is that intensive training with positive biofeedback may enhance postural control and stability in Parkinson's disease patients and in elderly fallers.


Condition Intervention
Parkinson's Disease Patients
Device: McROB Hybrid node 3-axes accelerometers and 3-axes gyroscopes

Genetics Home Reference related topics: familial paroxysmal nonkinesigenic dyskinesia Parkinson disease
MedlinePlus related topics: Parkinson's Disease
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Single Group Assignment
Official Title: Using Bio-Feedback for Improving Stability in Walking and Everyday Activity

Further study details as provided by Tel-Aviv Sourasky Medical Center:

Study Start Date: January 2008
Estimated Study Completion Date: November 2009
Estimated Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)
Intervention Details:
    Device: McROB Hybrid node 3-axes accelerometers and 3-axes gyroscopes
    Training with the Audio-feedback device for about 30 minutes, 3 times per week for 6 weeks
Detailed Description:

The aim of the study is to treat Parkinson's patients and elderly fallers. The intervention is intensive training with Biofeedback to try to correct stooped posture, and to improve stability in standing and in walking.

  Eligibility

Ages Eligible for Study:   50 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Idiopathic PD for >2 yrs
  • Between 50-90 Yrs
  • On anti-Parkinsonian medication
  • Hoehn & Yahr 2-3 in "ON"
  • Free of serious co-morbidities
  • Able to walk but reports difficulties in gait
  • Can use assistive device

Exclusion Criteria:

  • Significant orthopedic disturbances or pain
  • Major depression (DSM IV)
  • Dementia (MMSE<24)
  • Clinically significant hearing problems
  • Unstable medical condition (2 wks from meds change)
  • Deep Brain Stimulation
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00716261

Locations
Israel
Laboratory for gait and neurodynamics, Tel-Aviv Sourasky Medical Center
Tel-Aviv, Israel, 64239
Sponsors and Collaborators
Tel-Aviv Sourasky Medical Center
Investigators
Principal Investigator: Jeffrey M Hausdorff, PhD Laboratory for gait and neurodynamics, Tel-Aviv Sourasky Medical Center
  More Information

Responsible Party: Tel Aviv Sourasky Medical Center ( Laboratory for gait and neurodynamics, Tel Aviv Sourasky Medical center )
Study ID Numbers: 0204-08-TLV
Study First Received: July 14, 2008
Last Updated: July 15, 2008
ClinicalTrials.gov Identifier: NCT00716261  
Health Authority: Israel: Ministry of Health

Keywords provided by Tel-Aviv Sourasky Medical Center:
Parkinson's disease
Audio feedback
postural control

Study placed in the following topic categories:
Ganglion Cysts
Movement Disorders
Parkinson Disease
Basal Ganglia Diseases
Central Nervous System Diseases
Parkinsonian Disorders
Neurodegenerative Diseases
Brain Diseases

Additional relevant MeSH terms:
Nervous System Diseases

ClinicalTrials.gov processed this record on January 16, 2009